HIV11: Stribild Matches Efficacy and Tolerability of Atripla or Boosted Atazanavir at 96 Weeks
There are 1 comment on the HIV and Hepatitis story from Nov 27, 2012, titled HIV11: Stribild Matches Efficacy and Tolerability of Atripla or Boosted Atazanavir at 96 Weeks. In it, HIV and Hepatitis reports that:The Stribild single-tablet-regimen -- formerly dubbed the Quad -- demonstrated "robust and durable" efficacy and continued to be well-tolerated through 96 weeks, according to findings from 2 studies presented at the 11th International Congress on Drug Therapy in HIV Infection this month in Glasgow.
Join the discussion below, or Read more at HIV and Hepatitis.
#1 Jan 15, 2013
Learn more about the HIV/AIDS drug Atripla at http://www.rxwiki.com/atripla
Add your comments below
|Gov't report: Efforts to reduce US uninsured st...||May 21||kuda||22|
|CDC: 'Alarming' increase in STDs (Nov '15)||May 7||Dan||121|
|FDA Approves Generic Cholesterol Medication (Apr '06)||May 1||Dorian||47|
|Ring-ring: Cellphone interrupts Supreme Court h...||Apr 25||better call Saul||1|
|Mumps outbreak probably isn't related to vaccin...||Apr '17||MMR||1|
|Bristol Palin says abstinence best path for teens (May '09)||Apr '17||Coonway Tweety||2,658|
|After Trump rally, equity investors move into h...||Mar '17||Retribution||6|
Find what you want!
Search Biotech Forum Now
Copyright © 2017 Topix LLC